Transcatheter aortic valve implantation (TAVI) has become the standard of care for
inoperable patients, and the preferred treatment option for high-risk patients with severe …

Paravalvular aortic regurgitation (PAR) negatively affects the prognosis after transcatheter
aortic valve replacement (TAVR) with dramatically increased morbidity and mortality in …

Aim The impact of paravalvular regurgitation (PVR) following transcatheter aortic valve
replacement (TAVR) remains uncertain. In this analysis, we sought to evaluate the impact of …

Background Mild paravalvular regurgitation (PVR) remains a frequent and underappreciated
adverse event after transcatheter aortic valve implantation (TAVI) despite remarkable …

Importance Transcatheter aortic valve replacement (TAVR) is established for selected
patients with severe aortic stenosis. However, limitations such as suboptimal deployment …

Background—Significant postprocedural aortic regurgitation (AR) is observed in 10% to
20% of cases after transcatheter aortic valve replacement (TAVR). The prognostic value and …

Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice,
the treatment of aortic stenosis has changed dramatically. In the past, medical therapy with …

Significant mitral regurgitation (MR) is frequent in patients with severe aortic stenosis (AS). In
these cases, concomitant mitral valve repair or replacement is usually performed at the time …

Objectives: The aim of this study was to investigate the hemodynamic and clinical
performance of the Evolut PRO compared with its direct predecessor, the Evolut R …

As transcatheter aortic valve replacement becomes a more dominant treatment option
across all risk profiles, the frequency of encountering patients with multivalvular disease will …